Liu, Shuangyou
Deng, Biping
Yin, Zhichao
Pan, Jing
Lin, Yuehui
Ling, Zhuojun
Wu, Tong
Chen, Dong
Chang, Alex H.
Gao, Zhiyong
Song, Yanzhi
Zhao, Yongqiang
Tong, Chunrong
Article History
Received: 15 September 2019
Accepted: 21 January 2020
First Online: 6 February 2020
Conflict of interest
: A.H.C. is also a founding member of Shanghai YaKe Biotechnology Ltd., a biotechnology company focused on research and development of tumor cellular immunotherapy. The remaining authors declare no conflict of interest.